Market Place
Sourcing Support
GENFIT Announces Signature of the Share Purchase Agreement tis
29 Sep 2022 //
GLOBENEWSWIRE
Versant Ventures Launches Vector BioPharma AG
10 Aug 2022 //
WALDERWYSS
Versantis Presents New VS-01 Data at The International Liver CongressTM 2022
24 Jun 2022 //
BUSINESSWIRE
Versantis to Present Positive Phase 1b Data at AASLD for VS-01
15 Nov 2021 //
BIOSPACE
Versantis Appoints Prof Dr Katharina Staufer as Chief Medical Officer
19 Oct 2021 //
BUSINESSWIRE
Versantis Receives U.S. FDA Orphan Drug Designation for VS-01
07 Sep 2021 //
BUSINESSWIRE
Versant Ventures Acquires Portfolio Company Vividion Therapeutics
05 Aug 2021 //
BUSINESSWIRE
Versant-backed Bright Peak sets a date to bring its IL-2 into the clinic
10 Jun 2021 //
ENDPTS
With money pouring into biotech, Versant raises another $950M
22 Apr 2021 //
BIOPHARMADIVE
Versantis Announces Positive Phase 1b Results for VS-01 in Patients
17 Mar 2021 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.